Update on Telemedicine
Ministry of Health and Family Welfare (MoHFW) has developed a telemedicine application eSanjeevani which provides doctor to doctor and patient to doctor consultations. This application works on a hub and spoke model wherein doctors including specialists provide services to Health and Wellness Centres (HWCs) in rural areas. Further people in remote and rural areas can […]
Update on Access to Generic Medicines
To increase the access of generic medicines to the common man being sold through Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), the department has set a target to open 10,000 PMBJKs by March, 2024. Till 30.06.2023, 9,512 PMBJKs have been opened across the country. Further, Clause 1.5 of Indian […]
New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss
Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema (DME) Real-world data reinforce that first-line Vabysmo use improves outcomes and extends treatment intervals rapidly during the first four months for people with neovascular or ‘wet’ age-related macular degeneration (nAMD) and DME Clinical […]
It is important for every policy to evolve, and learnings need to be taken into consideration to improve them, to achieve the goal of creating better health outcomes for the citizens of the country: Dr. Mansukh Mandaviya at Health Ministry 's Swasthya Chintan Shivir in Dehradun
“It is important for every policy to evolve, and learnings need to be taken into consideration to improve them, to achieve the goal of creating better health outcomes for the citizens of the country.” This was stated by Dr. Mansukh Mandaviya, Union Health Minister, as he chaired the Swasthya Chintan Shivir, in the presence of […]
Positive Phase III results for Roche’s OCREVUS (ocrelizumab) twice a year, 10-minute subcutaneous injection in patients with multiple sclerosis
Phase III OCARINA II trial met primary and secondary endpoints OCREVUS twice a year, 10-minute injection has the potential to further improve the treatment experience and expand OCREVUS usage in MS centres with IV capacity limitations or without IV infrastructure OCREVUS remains the first and only therapy approved for both RMS and PPMS, and more […]
Union Minister for Health and Family Welfare Dr Mansukh Mandaviya to inaugurate Swasthya Chintan Shivir on 14th July, 2023 at Dehradun, Uttarakhand
Union Minister for Health and Family Welfare, Dr Mansukh Mandaviya will inaugurate the Swasthya Chintan Shivir on 14th July, 2023 at Dehradun, Uttarakhand. The two day Swasthya Chintan Shivir will be organized by the Ministry of Health and Family Welfare along with the Central Council of Health and Family Welfare. The event will be attended […]
JOINT NEWS RELEASE - 122 million more people pushed into hunger since 2019 due to multiple crises, reveals UN report
Over 122 million more people are facing hunger in the world since 2019 due to the pandemic and repeated weather shocks and conflicts, including the war in Ukraine, according to the latest State of Food Security and Nutrition in the World (SOFI) report published today jointly by five United Nations specialized agencies. If trends remain […]
Four-year follow up data for Roche’s Evrysdi show continued increase in number of children with a severe form of spinal muscular atrophy (SMA) able to sit, stand and walk
Data from ongoing FIREFISH study confirm long-term efficacy and safety profile of Evrysdi in children with Type 1 SMA Ninety-one percent of children were alive at month 48 More than 95% maintained the ability to swallow - without treatment they would have required feeding support and majority would have died within 2 years Evrysdi is […]
First WHO guidance on snakebite treatments published
The World Health Organization (WHO) has published the first in a series of WHO public-benefit target product profiles (TPPs) for snakebite treatments, in order to improve the quality of antivenoms available in the market. This is the first-ever guidance to improve the quality of such products. The TPP is a document that provides regulators, manufacturers, […]
CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Positive recommendation is based on interim data from ongoing RAINBOWFISH trial which showed majority of Evrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months’ treatment If approved by the European Commission, Evrysdi will be available to treat people of all ages with SMA in the European Union, […]
